These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35863054)

  • 1. Toll-like receptor triggering in systemic sclerosis: time to target.
    O'Reilly S
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI12-SI19. PubMed ID: 35863054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity in systemic sclerosis pathogenesis.
    O'Reilly S
    Clin Sci (Lond); 2014 Mar; 126(5):329-37. PubMed ID: 24219159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors in mediating pathogenesis in systemic sclerosis.
    Frasca L; Lande R
    Clin Exp Immunol; 2020 Jul; 201(1):14-24. PubMed ID: 32048277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll Like Receptors in systemic sclerosis: An emerging target.
    O'Reilly S
    Immunol Lett; 2018 Mar; 195():2-8. PubMed ID: 28888416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma: advances and opportunities for therapy.
    Brown M; O'Reilly S
    Curr Opin Rheumatol; 2018 Nov; 30(6):600-605. PubMed ID: 30234721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of toll-like receptors in systemic sclerosis.
    Ciechomska M; Cant R; Finnigan J; van Laar JM; O'Reilly S
    Expert Rev Mol Med; 2013 Aug; 15():e9. PubMed ID: 23985302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.
    Bhattacharyya S; Varga J
    Curr Rheumatol Rep; 2015 Jan; 17(1):474. PubMed ID: 25604573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy.
    Bhattacharyya S; Varga J
    Immunol Lett; 2018 Mar; 195():9-17. PubMed ID: 28964818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.
    Usategui A; Criado G; Izquierdo E; Del Rey MJ; Carreira PE; Ortiz P; Leonard WJ; Pablos JL
    Ann Rheum Dis; 2013 Dec; 72(12):2018-23. PubMed ID: 23413283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immunity in Systemic Sclerosis.
    Dowson C; Simpson N; Duffy L; O'Reilly S
    Curr Rheumatol Rep; 2017 Jan; 19(1):2. PubMed ID: 28116578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin-C in fibrosis in multiple organs: Translational implications.
    Bhattacharyya S; Midwood KS; Varga J
    Semin Cell Dev Biol; 2022 Aug; 128():130-136. PubMed ID: 35400564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
    Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S
    Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression profile of the toll-like receptor family in scleroderma dermal fibroblasts.
    Sakoguchi A; Nakayama W; Jinnin M; Wang Z; Yamane K; Aoi J; Makino K; Kajihara I; Ichihara A; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-4-9. PubMed ID: 24959869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
    Sun L; Liu W; Zhang LJ
    J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C drives persistence of organ fibrosis.
    Bhattacharyya S; Wang W; Morales-Nebreda L; Feng G; Wu M; Zhou X; Lafyatis R; Lee J; Hinchcliff M; Feghali-Bostwick C; Lakota K; Budinger GR; Raparia K; Tamaki Z; Varga J
    Nat Commun; 2016 Jun; 7():11703. PubMed ID: 27256716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting TLRs and the inflammasome in systemic sclerosis.
    Henderson J; Bhattacharyya S; Varga J; O'Reilly S
    Pharmacol Ther; 2018 Dec; 192():163-169. PubMed ID: 30081049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The
    Kavian N; Mehlal S; Jeljeli M; Saidu NEB; Nicco C; Cerles O; Chouzenoux S; Cauvet A; Camus C; Ait-Djoudi M; Chéreau C; Kerdine-Römer S; Allanore Y; Batteux F
    Front Immunol; 2018; 9():1896. PubMed ID: 30177933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis and immune dysregulation in systemic sclerosis.
    Chizzolini C; Brembilla NC; Montanari E; Truchetet ME
    Autoimmun Rev; 2011 Mar; 10(5):276-81. PubMed ID: 20863906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.
    Goh FG; Midwood KS
    Rheumatology (Oxford); 2012 Jan; 51(1):7-23. PubMed ID: 21984766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.